Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5084766016 | Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5084767013 | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5084768015 | Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Is a | Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form | true | Inferred relationship | Some | ||
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Plays role | Laxative therapeutic role | true | Inferred relationship | Some | ||
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Has active ingredient | Oxetacaine | true | Inferred relationship | Some | 1 | |
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Has active ingredient | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 2 | |
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Is a | Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) | true | Inferred relationship | Some | ||
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Has active ingredient | Aluminium hydroxide | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension | Is a | True | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets